Licensee Grant. Licensee grants to Flexera the right to reproduce, copy, host and distribute the Licensee FNO Products as necessary for Flexera to implement and provide the Cloud Site as set forth herein. Notwithstanding the foregoing, Licensee or its licensors own all right, title and interest in and to the Licensee FNO Products and related Licensee documentation, and in all proprietary and intellectual property rights related thereto, including but not limited to patent, copyright, trademark and trade secret rights wherever arising in the world. Subject to the limited licenses granted herein, no such rights are transferred to Flexera hereunder. Flexera will not use, copy, modify, distribute, or provide any third party access to the Licensee FNO Products except as contemplated under this Agreement. Flexera will not decompile, disassemble or reverse engineer the Licensee FNO Products. Licensee warrants that (i) it has the authority to grant to Flexera the license described herein and (ii) it shall use commercially available anti-virus software to test the Licensee FNO Products for viruses, worms, Trojan horses or other harmful, malicious or destructive code and such test has shown no such viruses, worms, Trojan horses or other harmful, malicious or destructive code.
Licensee Grant. Upon full execution of this Agreement, Licensee agrees to grant a worldwide, nonexclusive license and/or sublicense (commensurate to the scope of the licenses which Licensee has selected hereunder) under any and all AVC Essential Patent(s) that Licensee and its Affiliates, if any, have the right to license and/or sublicense, to any Licensor or any sublicensee of the Licensing Administrator desiring such a license and/or sublicense on fair and reasonable terms and conditions. For purposes of this Section 8.3 only, the Licensors’ per patent share of royalties which are payable pursuant to Article 3 of this Agreement shall be presumed to be a fair and reasonable royalty rate for the aforementioned license and/or sublicense to be granted by the Licensee.
Licensee Grant. 3.1 LICENSEE hereby grants, assigns, transfers and conveys to LICENSOR all of LICENSEE's right, title and interest in and to all IMPROVEMENTS in or upon LICENSED TECHNOLOGY, and any INTELLECTUAL PROPERTY therein, of any kind or description created or developed by LICENSEE or its SUBLICENSEES. This grant and assignment shall be absolute and irrevocable, shall survive the termination of this Agreement and is intended to entitle LICENSOR to use said IMPROVEMENTS for their academic purposes as more fully described in Section 2.4 of this Agreement, to entitle LICENSOR to license the LICENSED TECHNOLOGY and IMPROVEMENTS to third parties subsequent to termination of this Agreement and to entitle LICENSOR to collect royalties.
Licensee Grant. Licensee grants GM a non-transferable, non-exclusive, royalty-free, and worldwide license under all Licensee patents (including the right to make, have made, use, have used, offer for sale, and sell), copyrights (including the right to reproduce, create derivative works, distribute and publicly display or perform), trade secrets and other forms of intellectual property, excluding trademark rights, currently used by GM in the conduct of its business or as necessary in connection with GM’s marketing, advertising and promoting the services being performed by the Licensee under the Service Agreements. The license grant of this Section 3.5(b) is limited to use by GM in the conduct of its business and, other than as expressly set forth in Section 3.7 hereunder, GM is expressly prohibited from granting any sublicense to GM’s affiliates.
Licensee Grant. Subject to the terms and conditions of this Agreement, Licensee hereby grants, and shall cause its Affiliates to grant, to Genmab, a co-exclusive license under the Licensee Intellectual Property to: (i) Develop and have Developed the Licensed Compounds and Licensed Products; (ii) make, have made and otherwise Manufacture the Licensed Compounds and Licensed Products; and (iii) use, sell, offer to sell, have sold, import and otherwise Commercialize the Licensed Compounds and Licensed Products, in each case solely for purposes of performing activities as set forth in, and subject to the terms of, this Agreement during the term in the Field in the Territory. For the avoidance of doubt, the term “co-exclusive” shall mean that only Genmab and Licensee shall have the right to use the Licensee Intellectual Property to the exclusion of all others (save for permitted sublicensees under clause 4.3).
Licensee Grant. 5 4 Exclusive Use . . . . . . . . . . . . . . . . . . . . . . . . . . . .5
Licensee Grant. LICENSEE hereby grants to BYU all of LICENSEE's right, title and interest to any IMPROVEMENTS to the LICENSED TECHNOLOGY which are incorporated into the LICENSED PRODUCTS or LICENSED PROCESSES of any kind or description created or developed by LICENSEE or its SUBLICENSEES. This grant shall be absolute and irrevocable, shall survive the termination of this Agreement and is intended to entitle BYU to use said IMPROVEMENTS for its academic purposes as more fully described in Section of this Agreement, to entitle BYU to license the LICENSED TECHNOLOGY and IMPROVEMENTS to third parties subsequent to termination of this Agreement and to entitle BYU to collect royalties.
Licensee Grant. Licensee agrees to grant a worldwide, nonexclusive license and/or sublicense under any and all MPEG-2 Essential Patent(s) that Licensee or its Affiliate(s), if any, has the right to license and/or sublicense, to any Licensor or any sublicensee of the Licensing Administrator desiring such a license and/or sublicense on fair and reasonable terms and conditions. For purposes of this Section 7.3 only, the Licensors' per patent share of royalties payable pursuant to Section 3.1 of this
Licensee Grant. Licensee grants ESG Enterprise a royalty-free, worldwide, perpetual license to use and incorporate into ESG Enterprise products any suggestion, idea, enhancement, marketing, advertisement, feedback, recommendation, company name, quote, logo or other information Licensee provides to ESG Enterprise relating to Restricted Use Product or SaaS. Licensee grants ESG Enterprise anon-exclusive, nontransferable licenseto copy, store, transmit and use Licensee Data as necessary for Licensee’s use of Product or SaaS hereunder. Licensee represents and warrants that Licensee Data will not violate third party rights or applicable law.
Licensee Grant. 1. Dizmo herewith grants to Licensee a limited, revocable, non-exclusive, non- transferable and non-sublicenseable license to use the Software for your internal purposes only, as further described below, and only in accordance with, and subject to, the terms of this License Agreement.
